ReviewNaunyn-Schmiedeberg's archives of pharmacology2013

Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia.

Gerhard Gross et al.PubMed ↗Publisher ↗

No numbers read from the abstract.